• Publications
  • Influence
Remission in schizophrenia: proposed criteria and rationale for consensus.
New advances in the understanding of schizophrenia etiology, course, and treatment have increased interest on the part of patients, families, advocates, and professionals in the development ofExpand
  • 1,682
  • 200
  • PDF
The Structured Clinical Interview for DSM-III-R (SCID). II. Multisite test-retest reliability.
A test-retest reliability study of the Structured Clinical Interview for DSM-III-R was conducted on 592 subjects in four patient and two nonpatient sites in this country as well as one patient siteExpand
  • 1,602
  • 89
Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates.
OBJECTIVE Neuropsychological impairments are well documented in schizophrenia and are important targets of treatment. Information about the severity and pattern of deficits after treatment for theExpand
  • 884
  • 50
Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents.
CONTEXT Cardiometabolic effects of second-generation antipsychotic medications are concerning but have not been sufficiently studied in pediatric and adolescent patients naive to antipsychoticExpand
  • 809
  • 45
  • PDF
What does the PANSS mean?
OBJECTIVE Despite the frequent use of the Positive and Negative Syndrome Scale (PANSS) for rating the symptoms of schizophrenia, the clinical meaning of its total score and of the cut-offs that areExpand
  • 839
  • 39
Physical health monitoring of patients with schizophrenia.
OBJECTIVE Schizophrenia is associated with several chronic physical illnesses and a shorter life expectancy, compared with life expectancy in the general population. One approach to improving theExpand
  • 789
  • 32
  • PDF
Runs of homozygosity reveal highly penetrant recessive loci in schizophrenia
Evolutionarily significant selective sweeps may result in long stretches of homozygous polymorphisms in individuals from outbred populations. We developed whole-genome homozygosity association (WGHA)Expand
  • 303
  • 31
  • PDF
Treatment of schizophrenia with paliperidone extended-release tablets: A 6-week placebo-controlled trial
BACKGROUND Paliperidone extended-release tablet (paliperidone ER) is an investigational oral psychotropic developed for schizophrenia treatment. It utilizes OROS technology to provide a uniqueExpand
  • 258
  • 30
The Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II). II: Multi-site test-retest reliability study
A test-retest reliability study of the Structured Clinical Interview for DSM-III-R Personality Disorders (SCID-II) was conducted on 284 subjects in four psychiatric patient sites and twoExpand
  • 399
  • 27
Comparison of standard and low serum levels of lithium for maintenance treatment of bipolar disorder.
In recent years, lower serum levels have been recommended for maintenance therapy with lithium. We studied 94 patients with bipolar disorder in a randomized, double-blind, prospective trial of twoExpand
  • 383
  • 26
...
1
2
3
4
5
...